Background: Following interventions to eliminate trachoma in the Afar region of Ethiopia, our goal was to reassess the prevalence of trachomatous trichiasis (TT) and trachomatous inflammation-follicular (TF) at the woreda level, and to identify factors associated with the disease.
Methods: Cross-sectional community-based surveys were conducted in 26 trachoma-endemic woredas, employing a standardized approach. Households were selected as the secondary sampling unit. Surveys involved interviews with household heads, direct assessment of water, sanitation, and hygiene (WASH) access, and clinical examination of eligible household members for trachomatous trichiasis (TT) and trachomatous inflammation-follicular (TF).
Result: Overall, 18 out of the 26 woredas (69%) achieved the World Health Organization-recommended threshold for active trachoma elimination, with a prevalence of trachomatous inflammation-follicular (TF) below 5% in children aged 1-9 years. Additionally, 14 woredas (54%) met the threshold for trachomatous trichiasis (TT) elimination, with a prevalence of TT cases unknown to the health system below 0.2% in adults aged 15 years and older. However, access to improved drinking water sources within a 30-minute trip was limited to only 17% of households, and merely 9% had access to improved latrines. Addressing these WASH (Water, Sanitation, and Hygiene) challenges remains critical for sustaining progress in trachoma control and achieving long-term public health improvements in the Afar region.
Conclusion: In seven woredas, further rounds of antibiotic mass drug administration are required, complemented by initiatives to promote facial cleanliness and improve environmental conditions. Additionally, surgical campaigns for trachomatous trichiasis (TT) are needed in 12 woredas. There is a critical need to enhance access to improved Water, Sanitation, and Hygiene (WASH) facilities across all surveyed woredas to consolidate gains in trachoma control and achieve sustained public health improvements.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1186/s12879-024-10410-3 | DOI Listing |
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697634 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Impact of trachoma elimination efforts in afar regional state, Ethiopia: survey findings from 26 evaluation units.
BMC Infect Dis
January 2025
Ethiopia Ministry of Health, Addis Ababa, Ethiopia.
Background: Following interventions to eliminate trachoma in the Afar region of Ethiopia, our goal was to reassess the prevalence of trachomatous trichiasis (TT) and trachomatous inflammation-follicular (TF) at the woreda level, and to identify factors associated with the disease.
Methods: Cross-sectional community-based surveys were conducted in 26 trachoma-endemic woredas, employing a standardized approach. Households were selected as the secondary sampling unit.
Trachoma Impact Survey Results from 31 Woredas in Tigray Region, Ethiopia.
Ophthalmic Epidemiol
December 2024
Light for the World, Addis Ababa, Ethiopia.
Purpose: Baseline surveys were conducted in Tigray region, Ethiopia, in 2013. Since then, rounds of azithromycin mass drug administration (MDA) have been delivered in-line with international guidance. The purpose of these surveys was to assess trachomatous inflammation-follicular (TF) prevalence following those treatments to enable the region to plan the next steps towards elimination of trachoma.
View Article and Find Full Text PDFThe FLuorometholone as Adjunctive MEdical Therapy for Trachomatous Trichiasis Surgery (FLAME) Trial: Study Design.
Ophthalmic Epidemiol
December 2024
Department of Ophthalmology and Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
Purpose: To report the design of FLuorometholone as Adjunctive MEdical therapy for TT surgery (FLAME) trial.
Design: Parallel design, double-masked, placebo-controlled clinical trial with 1:1 randomization to fluorometholone 0.1% eye drops twice daily or placebo twice daily for 4 weeks in eyes undergoing trachomatous trichiasis (TT) surgery for assessing the efficacy, safety, and cost-effectiveness of fluorometholone 0.
Cross-cultural adaptation of the 5-Question Stigma Indicators in trachoma-affected communities, Ethiopia.
PLOS Ment Health
November 2024
International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Article Synopsis
- * The study involved 390 participants, including those with and without trachomatous trichiasis, and focused on the relevance of stigma-related issues like shame and social avoidance within the cultural context.
- * Both stigma scales demonstrated acceptable internal consistency and cultural validity, with the 5-QSI-AP and 5-QSI-CS showing promising results for assessing stigma, indicating they can help monitor stigma in afflicted populations.
Assessing the prevalence of trachoma in the East, North, Far North and Adamaoua regions of Cameroon, 2016-2022.
Int Health
November 2024
Faculté de médecine et des Sciences Biomédicales, Université de Yaoundé, Yaoundé, Cameroon.
Article Synopsis
- Trachoma is still a significant health issue in parts of Cameroon, particularly in the northern regions, where surveys from 2016-2022 revealed ongoing cases of active trachoma and trichiasis, despite previous interventions.
- A total of 151,800 individuals were examined in these surveys, and findings indicated that two evaluation units exceeded the 5% threshold for active trachoma, while ten units exceeded the 0.2% threshold for trichiasis.
- Continued intervention efforts, including mass antibiotic distribution and improved surgical access, are needed to address these health challenges, with future assessments required to gauge progress towards eliminating trachoma as a public health concern.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!